Search Results 391-400 of 17050 for monoclonal antibody
Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the patient's immune system attack the cancer, and may interfere with the ability ...
Denosumab is a monoclonal antibody that is used to treat bone loss in order to reduce the risk of bone fractures in healthy people, and to reduce new bone ...
And the Food and Drug Administration has approved monoclonal antibody therapies Inmazeb and Ebanga to treat Ebola. Therapy. Supportive care may help you feel ...
... antibodies predict a worse prognosis. ... Bahn says: "We treated GO fibroblasts with a high-affinity human stimulatory monoclonal antibody directed against TSH ...
About this study ... Monoclonal antibodies, such as pembrolizumab, may block tumor growth in different ways by targeting certain cells. Drugs used in chemotherapy ...
Monoclonal antibodies, such as pembrolizumab, may interfere with the ability of cancer cells to grow and spread. Drugs used in chemotherapy, such as ...
The first calcitonin gene-related peptide monoclonal antibody to prevent migraine was approved in 2018. Today, four drugs have been approved: Eptinezumab ...
Monoclonal antibodies, such as trastuzumab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find ...
Monoclonal antibodies, such as pembrolizumab, may interfere with the ability of tumor cells to grow and spread. Epacadostat may stop the growth of tumor ...
The extraordinary mutation of the Omicron variant has caused us to lose two sets of monoclonal antibodies, leaving us with one monoclonal antibody for ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift before July 31 and it can be doubled in impact thanks to a $100,000 Summer Challenge.